Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 151 of 151 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/02/13
End: 06/30/19
Due: 06/30/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia | NCT02175693 | Eisai Co., Ltd. | user2@example.com | None | 2013-04-02 | 2019-06-30 | 2020-06-30 | - | - | 2025-07-14 |